SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News

Stem Cell Infusion Cut Fractures; Testosterone for Menopause; BMD and Cognition

— News and commentary from the endocrinology world

GLP-1 Lawsuits Over Eye Risk; Hospital Oxygen Supply Cut; Top Causes of U.S. Deaths

Health news and commentary gathered by MedPage Today staff

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Thyroid Meds Recalled Nationwide; Life Expectancy Rebounds; Cannabis Use Hits Record

Health news and commentary gathered by MedPage Today staff

The Medicare GLP-1 Discount Has One Big Catch: Some Sick Patients Don't Qualify

The $50 price under the program applies only to people using the drug solely for weight loss

Todays Updates

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Liver Failure or Liver Mets?

Diagnosis complicated by absence of radiologic evidence of hepatic lesions

Here's Why Hematuria in a Young Patient Should Always Be Investigated

Terminology also makes a difference

Todays Updates

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Liver Failure or Liver Mets?

Diagnosis complicated by absence of radiologic evidence of hepatic lesions

Here's Why Hematuria in a Young Patient Should Always Be Investigated

Terminology also makes a difference

Latest News

— News and commentary from the endocrinology world

Health news and commentary gathered by MedPage Today staff

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Health news and commentary gathered by MedPage Today staff

The $50 price under the program applies only to people using the drug solely for weight loss

News All Time

ADA Says Booted Meeting Attendees Violated Code of Conduct

Expelled researchers unhappy with conclusion of organization's review

Off-Label GLP-1 Use Skyrockets in Young Kids

Weight-loss formulations are only approved for kids 12 years and older

Endometriosis Can Elude Diagnosis for Years. What to Know About New Ways to Find It.

New tests available abroad are raising hope among doctors and patients

New GLP-1 Hair Loss Insights; Wegovy in Kids; Are Fitness Trackers Lying to Users?

News and commentary from the endocrinology world

Preschoolers With Cystic Fibrosis Get Close to Normal on Alyftrek

TIMBERLINE study shows good safety and sweat chloride reductions with triple combo CFTR modulator

Menopausal Hormone Therapy May Ease Severe Mood Symptoms

Therapy also associated with better sleep scores in non-controlled study

The CDC Division I Spent 15 Years Building Is in Peril

Cuts to the Division of Nutrition, Physical Activity, and Obesity will not make America healthy

The Market Forces Quietly Adding Thousands to Patient Bills

A look at a shifting industry

Preserving Muscle During GLP-1 Weight Loss

Experts advise tracking body composition, boosting protein, and resistance training

Early T1D Screening Guide; FDA Clears Mint Patch Pump; GLP-1s and Fertility

News and commentary from the endocrinology world

ADA Boycott Follows Meeting Scandal; Lawsuits Fly in Residency Application Space

MedPage Today reporters offer further insights into recently covered topics

Pentagon Revives Testosterone Testing After Pause, Excludes Women

The Pentagon is reinstituting a mandatory testing program for testosterone deficiency among US service members age 30 and older, a spokesperson ⁠said on Thursday, bringing...

Osteoporosis: Are Bone Density Targets Worth Chasing?

Specialists debate the value of specific bone density goals with concerns that measurement variability and limited trial evidence may complicate treatment decisions.

GLP-1 Systematic Review Finds Weight Loss of Up to 24%

GLP-1 drugs are associated with substantial weight loss in adults without diabetes, and the range of options, including oral and multiagonist therapies, is expanding.

Nurse-Led Digital Therapeutics Boosts Diabetes Outcomes

A structured nurse-led digital therapeutics pathway is linked to higher adherence and more favorable metabolic outcomes than usual care in adults with type 2 diabetes, a study reports.

FDA Approves Generic Lutathera for Adults With GEP-NETs

Bexlutry is the first radioligand equivalent approved by the agency for treatment of the rare tumors.

Recommended News For You

Higher levels of HIF2α found to slow down aggressive childhood cancer

New CAR T-Cell Therapy Approved for Leukemia

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

One-third of childhood cancer survivors experience significant fear that it could come back, study reveals

Urinary tract cancer prediction models with high sensitivity and specificity

Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer

It Is Not Just the Royals Who Go Through Cancer.

Recommended Articles For You

Modern Approaches to Detecting Residual Disease: Clinical Utility and Future Trends 

Understanding Iron Saturation Levels in Your Blood  

Exosomes in Cancer: A Novel Frontier for Therapy and Biomarker Discovery 

Exercise Capacity During Cancer Recovery: Mechanisms, Clinical Implications, and Evidence-Based Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Truth About Apple AirPods

2.

Check for eating disorders in bipolar disorder patients.

3.

Fitness levels for the heart and lungs are linked to a lower mortality from cancer in men.

4.

According to a study, patients with ovarian cancer who undergo aggressive surgery have a 70% lower chance of dying.

5.

Transperineal Biopsy IDs Active Surveillance Candidates

1.

The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies

2.

Engineered Hematopoietic Niche Modulation for Bone Marrow Recovery

3.

Bone Marrow Functional Reserve Screening in Healthy Aging

4.

Altered Bone-Marrow Microenvironment Dynamics During Ineffective Hematopoiesis

5.

Tumor Ecosystem Profiles for Therapy Matching

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

3.

Understanding the Role of Screening in Cancer Prevention

4.

Cancer Care: From Awareness to Recovery

5.

Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot